BMS-986120

BMS-986120 Suppliers list
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai Tube Pharmaceutical Co., Ltd.  
Tel: 021-54338626 18017892860
Email: sales@tubepharm.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Email: liming@bio-fount.com
Company Name: Shanghai zhigan biotechnology co., LTD  
Tel:
Email: zhiqianbio@126.com

BMS-986120 manufacturers

  • BMS-986120
  • BMS-986120 pictures
  • $1410.00
  • 2026-07-27
  • CAS:1478712-37-6
  • Purity:
  • Supply Ability: 10g
BMS-986120 Basic information
Product Name:BMS-986120
Synonyms:BMS-986120;BMS-986120 1478712-37-6;2-methoxy-6-[6-methoxy-4-[[5-methyl-2-(4-morpholinyl)-4-thiazolyl]methoxy]-2-benzofuranyl]-imidazo[2,1-b]-1,3,4-thiadiazole;Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[[5-methyl-2-(4-morpholinyl)-4-thiazolyl]methoxy]-2-benzofuranyl]-;BMS986120,BMS 986120
CAS:1478712-37-6
MF:C23H23N5O5S2
MW:513.59
EINECS:
Product Categories:
Mol File:1478712-37-6.mol
BMS-986120 Structure
BMS-986120 Chemical Properties
density 1.57±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble in DMSO
pka4.87±0.10(Predicted)
form A crystalline solid
color White to off-white
Safety Information
MSDS Information
BMS-986120 Usage And Synthesis
UsesBMS-986120 is a first-in-class oral and reversible protease-activated receptor 4 (PAR4) antagonist, with IC50s of 9.5 nM and 2.1 nM in human and monkey blood, respectively. BMS-986120 has potent and selective antiplatelet effects[1][2].
in vivo

In monkeys, BMS-986120 (1 mg/kg) does not inhibit PA induced by PAR1-AP, ADP and collagen, supporting selectivity. BMS-986120 (0.2, 0.5, 1 mg/kg) reduces TW by 35±5, 49±4, and 83±4%, respectively. Maximum KBT and MBT increases are only 2.2-fold and 1.8-fold, respectively[1].

IC 50PAR1; PAR4
References[1] Pancras C Wong, et al. Abstract 175: A Novel Orally-Active Small-Molecule Antagonist of the Platelet Protease-Activated Receptor-4, BMS-986120, Inhibits Arterial Thrombosis With Limited Impact on Hemostasis in Cynomolgus Monkeys. Stroke. 2018;47:A175.
[2] Wilson SJ, et al. PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex VivoThrombus Formation. Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):448-456. DOI:10.1161/ATVBAHA.117.310104
[3] Wong PC, et al. Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding. Sci Transl Med. 2017 Jan 4;9(371). DOI:10.1126/scitranslmed.aaf5294
BMS-986120 Preparation Products And Raw materials
Tag:BMS-986120(1478712-37-6) Related Product Information
(R)-2-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanoic acid BMS 777607 BMS-986205 BMS-986120 AZD1283 Vorapaxar